Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Gynecologic Oncology
|
September 11, 2016
Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States
Alexander Melamed, Emily M Hinchcliff, Joel T Clemmer, et al.
Annals of Surgical Oncology
|
May 10, 2015
Same-Day Discharge After Laparoscopic Hysterectomy for Endometrial Cancer
Alexander Melamed, Jennifer L Katz Eriksen, Emily M Hinchcliff, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 24, 2014
Clinical outcomes of women with recurrent or persistent uterine leiomyosarcoma
Jose Alejandro Rauh-Hain, Emily M Hinchcliff, Titilope Oduyebo, et al.
Iscience
|
May 10, 2024
Phase 1b study of batiraxcept in combination with durvalumab in patients with platinum-resistant ovarian cancer
Anne Knisely, Emily M Hinchcliff, Elisabeth Gardiner, et al.
Gynecologic Oncology
|
September 15, 2018
A practical guide for the safe implementation of early phase drug development and immunotherapy program in gynecologic oncology practice
Amir Jazaeri, Robert L Coleman, Anil K Sood, et al.
Cancer
|
November 27, 2023
Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer
Emily M Hinchcliff, Anne Knisely, Naomi Adjei, et al.
The New England Journal of Medicine
|
March 27, 2023
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
Ramez N Eskander, Michael W Sill, Lindsey Beffa, et al.
Nature Medicine
|
March 5, 2025
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial
Ramez N Eskander, Michael W Sill, Lindsey Beffa, et al.
Nature
|
July 3, 2025
PPP2R1A mutations portend improved survival after cancer immunotherapy
Yibo Dai, Anne Knisely, Mitsutake Yano, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Gynecologic Oncology
|
September 11, 2016
Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States
Alexander Melamed, Emily M Hinchcliff, Joel T Clemmer, et al.
Annals of Surgical Oncology
|
May 10, 2015
Same-Day Discharge After Laparoscopic Hysterectomy for Endometrial Cancer
Alexander Melamed, Jennifer L Katz Eriksen, Emily M Hinchcliff, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 24, 2014
Clinical outcomes of women with recurrent or persistent uterine leiomyosarcoma
Jose Alejandro Rauh-Hain, Emily M Hinchcliff, Titilope Oduyebo, et al.
Iscience
|
May 10, 2024
Phase 1b study of batiraxcept in combination with durvalumab in patients with platinum-resistant ovarian cancer
Anne Knisely, Emily M Hinchcliff, Elisabeth Gardiner, et al.
Gynecologic Oncology
|
September 15, 2018
A practical guide for the safe implementation of early phase drug development and immunotherapy program in gynecologic oncology practice
Amir Jazaeri, Robert L Coleman, Anil K Sood, et al.
Cancer
|
November 27, 2023
Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer
Emily M Hinchcliff, Anne Knisely, Naomi Adjei, et al.
The New England Journal of Medicine
|
March 27, 2023
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
Ramez N Eskander, Michael W Sill, Lindsey Beffa, et al.
Nature Medicine
|
March 5, 2025
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial
Ramez N Eskander, Michael W Sill, Lindsey Beffa, et al.
Nature
|
July 3, 2025
PPP2R1A mutations portend improved survival after cancer immunotherapy
Yibo Dai, Anne Knisely, Mitsutake Yano, et al.
Page
of 2